StockData
Apnimed, Inc. logo

Apnimed, Inc. (APMD) stock

APMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026
$17.80+1.52 (+9.34%)

Close on Nov 17, 2026Market cap $85.47MP/E –Yield –

Apnimed total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Apnimed's total debt was $40.27M at Jun 30, 2026. For fiscal 2025 it was $0.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$40.27M–
Q4 FY2025Dec 31, 2025$0–

More Apnimed figures

See a number that looks wrong?